OBJECTIVE: Few studies have examined the effectiveness of shared decision making (SDM) in clinical practice. This study evaluated the impact of SDM on quality of life and symptom control in children with asthma. METHODS: We conducted a prospective 3-year study in six community-based practices serving a low-income patient population. Practices received training on SDM using an evidence-based toolkit. Patients aged 2-17 with a diagnosis of asthma were identified from scheduling and billing data. At approximate 6-month intervals, patients completed a survey consisting of the Mini Pediatric Asthma Quality of Life Questionnaire (range 1-7) and the control domain of the Pediatric Asthma Therapy Assessment Questionnaire (range 0-7). We used propensity scores to match 46 children receiving SDM to 46 children receiving usual care with decision support. Included children had completed a baseline survey and at least one follow-up survey. Random coefficient models incorporated repeated measures to assess the effect of SDM on asthma quality of life and asthma control. RESULTS: The sample was primarily of non-White patients (94.6%) with Medicaid insurance (92.4%). Receipt of SDM using an evidence-based toolkit was associated with higher asthma quality of life [mean difference 0.9; 95% confidence interval (CI) 0.4-1.4] and fewer asthma control problems (mean difference -0.9; 95% CI -1.6--0.2) compared to usual care with decision support. CONCLUSIONS: Implementation of SDM within clinical practices using a standardized toolkit is associated with improved asthma quality of life and asthma control for low-income children with asthma when compared to usual care with decision support.
OBJECTIVE: Few studies have examined the effectiveness of shared decision making (SDM) in clinical practice. This study evaluated the impact of SDM on quality of life and symptom control in children with asthma. METHODS: We conducted a prospective 3-year study in six community-based practices serving a low-income patient population. Practices received training on SDM using an evidence-based toolkit. Patients aged 2-17 with a diagnosis of asthma were identified from scheduling and billing data. At approximate 6-month intervals, patients completed a survey consisting of the Mini Pediatric Asthma Quality of Life Questionnaire (range 1-7) and the control domain of the Pediatric Asthma Therapy Assessment Questionnaire (range 0-7). We used propensity scores to match 46 children receiving SDM to 46 children receiving usual care with decision support. Included children had completed a baseline survey and at least one follow-up survey. Random coefficient models incorporated repeated measures to assess the effect of SDM on asthma quality of life and asthma control. RESULTS: The sample was primarily of non-White patients (94.6%) with Medicaid insurance (92.4%). Receipt of SDM using an evidence-based toolkit was associated with higher asthma quality of life [mean difference 0.9; 95% confidence interval (CI) 0.4-1.4] and fewer asthma control problems (mean difference -0.9; 95% CI -1.6--0.2) compared to usual care with decision support. CONCLUSIONS: Implementation of SDM within clinical practices using a standardized toolkit is associated with improved asthma quality of life and asthma control for low-income children with asthma when compared to usual care with decision support.
Entities:
Keywords:
Asthma therapy assessment questionnaire (ATAQ); Medicaid; mini asthma quality of life questionnaire (AQLQ); practice-based research; propensity score
Authors: Michael F Dulin; Thomas M Ludden; Hazel Tapp; Heather A Smith; Brisa Urquieta de Hernandez; Joshua Blackwell; Owen J Furuseth Journal: J Am Board Fam Med Date: 2010 Jan-Feb Impact factor: 2.657
Authors: Elizabeth A Skinner; Gregory B Diette; Pamela J Algatt-Bergstrom; Theresa T H Nguyen; Rebecca D Clark; Leona E Markson; Albert W Wu Journal: Dis Manag Date: 2004
Authors: Jasmina I Ivanova; Rachel Bergman; Howard G Birnbaum; Gene L Colice; Robert A Silverman; Kimmie McLaurin Journal: J Allergy Clin Immunol Date: 2012-02-11 Impact factor: 10.793
Authors: Sandra R Wilson; Peg Strub; A Sonia Buist; Sarah B Knowles; Philip W Lavori; Jodi Lapidus; William M Vollmer Journal: Am J Respir Crit Care Med Date: 2009-12-17 Impact factor: 21.405
Authors: L Indinnimeo; F Chiarotti; V De Vittori; L Baldini; G De Castro; A M Zicari; G Tancredi; L Leonardi; M Duse Journal: Int J Immunopathol Pharmacol Date: 2014 Apr-Jun Impact factor: 3.219
Authors: Kelly Reeves; Katherine O'Hare; Lindsay Shade; Thomas Ludden; Andrew McWilliams; Melinda Manning; Melanie Hogg; Stacy Reynolds; Christopher M Shea; Elizabeth C Burton; Melissa Calvert; Diane M Derkowski; Hazel Tapp Journal: Implement Sci Commun Date: 2020-03-04
Authors: Wen Ming Koh; Ahmad Ihsan Abu Bakar; Norita Hussein; Hilary Pinnock; Su May Liew; Nik Sherina Hanafi; Yong Kek Pang; Bee Kiau Ho; Salbiah Mohamed Isa; Aziz Sheikh; Ee Ming Khoo Journal: Health Expect Date: 2021-08-27 Impact factor: 3.377